Novartis
Abbott
Our structural heart portfolio includes transcatheter mitral valve repair devices, transcatheter aortic valve replacement, mechanical and tissue valves and structural heart occluders.
Our electrophysiology and cardiac rhythm management devices include pacemakers, implantable cardiac defibrillators, diagnostic and ablation catheters, mapping and visualization systems and implantable cardiac monitors.
Solutions for treating heart failure with left ventricular assist devices, cardiac rensynchronization therapy and a pulmonary artery pressure monitoring system means Abbott offers the world’s leading portfolio of solutions for heart failure therapy. https://www.abbott.com/
Bayer
At Bayer, we’re committed to drive sustainable development and generate a positive impact with our businesses.
Through bold ideas and unprecedented insights, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by empowering everyday health, improving approaches to patient care, and finding better ways to nourish our communities around the world. https://www.bayer.com/en/
Boehringer
Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
In the India, Middle East, Turkey and Africa region, over 2000 employees serve more than 70 markets across Human Pharma and Animal Health, with its headquarters based in Dubai, United Arab Emirates. https://www.boehringer-ingelheim.com/
CSL Vifor
At CSL Vifor, our vision is to be the global leader in iron deficiency and nephrology. We strive to help patients around the world with severe, chronic and rare diseases lead better, healthier lives. Building on our strong expertise in the treatment of iron deficiency, we continue to expand into nephrology and rare diseases.
Over several decades, we have proven our ability to identify and serve therapeutic areas with significant unmet medical need, successfully building on our expertise and track record to create new markets.
We have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease. This is supported by our founding heritage and expertise in iron deficiency therapy, helping to support a broad range of patients in need. https://www.viforpharma.com/
AstraZeneca
Our bold ambition is to stop, reverse and cure CVRM diseases by maximising our medicines, delivering innovative solutions, and advancing our pipeline. We are fundamentally transforming CVRM care.
From prevention to treatment to improved survival, we empower patients with cardiovascular and metabolic diseases to do more. https://www.astrazeneca.com/
pfizer
We strive to set the standard for quality, safety and value in the discovery, development, and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. https://www.pfizer.com/